DJIA 18,232.02 -53.72 -0.29%
NASDAQ 5,089.36 0.00 0.00%
S&P 500 2,126.06 -4.76 -0.22%
market minute promo

INSMED, INC. (NASDAQ: INSM)

22.61 -0.15 (-0.66%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

INSM $22.61 -0.66%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $22.80
Previous Close $22.76
Daily Range $22.44 - $23.07
52-Week Range $11.25 - $24.00
Market Cap $1.4B
P/E Ratio -11.14
Dividend (Yield) $0.00 (0.0%)
Volume 165,377
Average Daily Volume 463,161
Current FY EPS -$2.04

Sector

Healthcare

Industry

Drug Makers

INSMED, INC. (INSM) Description

A biopharmaceutical company focused on the development and commercialization of drugs to treat metabolic diseases, endocrine disorders and oncology within niche markets that have unmet medical needs. Website: http://www.insmed.com/

News & Commentary Rss Feed

This Week in Biotech: A Double-Dose of Hot Potato

Two pharma giants walk away from collaborations, another investigational drug receives the breakthrough designation, and more M&A activity are this week's biggest biotech stories.

Use Options For a Chance To Buy INSM at a 62% Discount

Use Options For a Chance To Buy INSM at a 55% Discount

Morning Market Losers

Benzinga's Top #PreMarket Losers

Books-A-Million, HomeAway, Vaalco Energy Lead Monday's After-Hours Movers

Should You Buy Insmed Incorporated Ahead of Earnings? - Tale of the Tape

Use Options For a Chance To Buy INSM at a 52% Discount

Update: Insmed Q3 2014 Earnings

Insmed's (INSM) CEO Bill Lewis on Q3 2014 Results - Earnings Call Transcript

Insmed (INSM) Q3 2014 Results - Earnings Call Webcast

See More INSM News...

INSM's Top Competitors

INSM $22.61 (-0.66%)
Current stock: INSM
AMGN $163.58 (-0.16%)
Current stock: AMGN
GILD $111.71 (0.44%)
Current stock: GILD
BIIB $398.68 (-0.62%)
Current stock: BIIB